1181 related articles for article (PubMed ID: 6547074)
1. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
[TBL] [Abstract][Full Text] [Related]
2. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
Reiner GC; Katzenellenbogen BS
Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
[TBL] [Abstract][Full Text] [Related]
3. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
[TBL] [Abstract][Full Text] [Related]
4. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
5. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
[TBL] [Abstract][Full Text] [Related]
6. Estrone receptor formation during the processing of estradiol-receptor complex in MCF-7 cells.
Hansen ER; Brooks SC
Cancer Res; 1982 May; 42(5):1967-74. PubMed ID: 7066908
[TBL] [Abstract][Full Text] [Related]
7. Failure of estradiol immunofluorescence in MCF-7 breast cancer cells to detect estrogen receptors.
Mercer WD; Edwards DP; Chamness GC; McGuire WL
Cancer Res; 1981 Nov; 41(11 Pt 1):4644-52. PubMed ID: 7030480
[TBL] [Abstract][Full Text] [Related]
8. Binding characteristics and biological activity of 17 alpha-[125I]iodovinyl-11 beta-methoxyestradiol, an estrogen receptor-binding radiopharmaceutical, in human breast cancer cells (MCF-7).
McManaway ME; Jagoda EM; Eckelman WC; Larson SM; Francis BE; Gibson RE; Reba RC; Lippman ME
Cancer Res; 1986 May; 46(5):2386-9. PubMed ID: 3697981
[TBL] [Abstract][Full Text] [Related]
9. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
[TBL] [Abstract][Full Text] [Related]
10. Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to the estrogen receptor of MCF-7 cells in cytosolic extracts and in nuclei of intact cells.
Schütze N; Vollmer G; Wünsche W; Grote A; Feit B; Knuppen R
Exp Clin Endocrinol; 1994; 102(5):399-408. PubMed ID: 7867704
[TBL] [Abstract][Full Text] [Related]
11. Specific estrogen receptor binding and biological effects of 16 alpha-iodoestradiol on human breast cancer cells.
Lippman ME; Do HM; Hochberg RB
Cancer Res; 1981 Aug; 41(8):3150-4. PubMed ID: 7248972
[TBL] [Abstract][Full Text] [Related]
12. Interaction of ionizing irradiation with steroid receptors in human breast cancer cells.
Janssens JP; Wittevrongel C; De Loecker W
Cancer Res; 1984 Dec; 44(12 Pt 1):5650-6. PubMed ID: 6541968
[TBL] [Abstract][Full Text] [Related]
13. Effects of estradiol on estrogen receptor, progesterone receptor, and tyrosinase in hamster melanoma transplanted into athymic mice.
Hitselberger MH; Schleicher RL; Beattie CW
Cancer Res; 1988 Jul; 48(13):3720-7. PubMed ID: 3132319
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of an estrogen-inhibited variant derived from the MCF-7 breast cancer cell line.
Bronzert DA; Triche TJ; Gleason P; Lippman ME
Cancer Res; 1984 Sep; 44(9):3942-51. PubMed ID: 6744309
[TBL] [Abstract][Full Text] [Related]
15. Nuclear estradiol-binding sites in human breast cancer.
Vandewalle B; Peyrat JP; Bonneterre J; Hecquet B; Dewailly D; Lefebvre J
Cancer Res; 1983 Sep; 43(9):4497-503. PubMed ID: 6683589
[TBL] [Abstract][Full Text] [Related]
16. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.
Katzenellenbogen BS; Kendra KL; Norman MJ; Berthois Y
Cancer Res; 1987 Aug; 47(16):4355-60. PubMed ID: 3607768
[TBL] [Abstract][Full Text] [Related]
17. Antiestrogen pharmacology and mechanism of action.
Katzenellenbogen BS; Miller MA; Eckert RL; Sudo K
J Steroid Biochem; 1983 Jul; 19(1A):59-68. PubMed ID: 6887873
[TBL] [Abstract][Full Text] [Related]
18. Effect of growth on the estrogen receptor levels in MCF-7 cells.
Brooks SC; Hansen ER; Saunders DE; Battelli MG; Shafie SM
Cancer Res; 1984 Sep; 44(9):3724-9. PubMed ID: 6744290
[TBL] [Abstract][Full Text] [Related]
19. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.
Benz C; Hollander C; Miller B
Cancer Res; 1986 May; 46(5):2276-81. PubMed ID: 3697973
[TBL] [Abstract][Full Text] [Related]
20. Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells.
Eckert RL; Katzenellenbogen BS
Cancer Res; 1982 Jan; 42(1):139-44. PubMed ID: 7053842
[No Abstract] [Full Text] [Related]
[Next] [New Search]
